Repinotan in Patients With Acute Ischemic Stroke

Update Il y a 4 ans
Reference: NCT00044915

Woman and Man

Extract

The purpose of this trial is to evaluate Repinotan HCl in patients with acute ischemic stroke. At study entry patients will be randomized to Repinotan HCl or placebo in a 1:1 ratio. The total treatment period wil be 72 hours.


Inclusion criteria

  • Stroke ,Acute ischemic stroke


Links